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base (NHIRD) to investigate the relationship of urolithiasis and acute
myocardial infarction (AMI).
Materials and Methods: Patients with the diagnosis of urolithiasis (ICD-9-
CM codes 592.0, 592.1, 592.9) before Jan 1, 2003 were retrieved from the
NHIRD's Longitudinal Health Insurance Database 2005 as the case group.
Patients without urolithiasis werematched with 1:4 ratio regarding to sex,
age and comorbidities as control group. Both groups were followed till
myocardial infarction were encountered (ICD-9-CM codes 410, 411, 412,
413, 414, or 440) or till the end of 2012.
Results: Total 37,052 cases and 148,209 controls were inducted into this
study. The risk of AMI was higher among patients with urolithiasis
(adjusted hazard ratio [aHR] 1.07, 95% conﬁdence interval [CI] 1.03e1.13).
We detected a signiﬁcant association between urinary calculi and intu-
bation (aHR 1.53, 95% CI 1.36e1.73), intensive care unit treatment (aHR
1.22, 95% CI 1.13e1.32), heart failure (aHR 1.59, 95% CI 1.42e1.78), shock
(aHR 1.53, 95% CI 1.32e1.77) and arrhythmias (aHR 1.18, 95% CI 1.06e1.33).
Patients with kidney stones have the highest risk of AMI.
Conclusion: Urolithisis is associated with higher risks of AMI and several
complications of AMI. Treating urolithiasis more aggressively is recom-
mended for patients with comorbidities related to AMI.Laparoscopy
NDP100:
IMPACT OF POSITIVE SURGICAL MARGIN ON PROSTATE CANCER
RECURRENCE AFTER ROBOT-ASSISTED LAPAROSCOPIC RADICAL
PROSTATECTOMY
Sheng-Tang Wu, Chien-Chang Kao, Chu-Wei Tsao, Shou-Hung Tang, En
Meng, Guang-Huan Sun, Dah-Shyong Yu, Pao-Luo Fan, Hong-I.
Chen, Sun-Yran Chang, Tai-Lung Cha. Division of Urology, Department of
Surgery, Tri-Service General Hospital, National Defense Medical Center,
Taipei, Taiwan
Purpose: We analyzed the impact of positive surgical margins on prostate
speciﬁc antigen (PSA) recurrence in patients after robot-assisted laparo-
scopic radical prostatectomy (RARP) as deﬁnitive local treatment for
prostate cancer
Materials and Methods: There were 294 consecutive patients who un-
derwent RARP for prostate cancer between Jan 2008 and Aug 2013. Pa-
tients without undetectable PSA within 3 months after RARP, or with
postoperative adjuvant radiotherapy due to adverse pathological features
that suggested by NCCN guideline were excluded. We retrospectively
analyzed the records of 219 patients. Demographic features, initial and
followed PSA, Gleason score, and pathologic stage of prostate were
reviewed.
Results: A total of 20 patients (9.1%) developed biochemical recurrence.
Forty-one patients (18.7%) with positive surgical margins (PSM+). In all
patients (n¼ 219), with biochemical recurrence (BCR+, n¼ 20), and no BCR
(BCR-, n¼ 199) patients group, the mean agewas 64.6, 61.9, and 64.9 years
in each group; the mean follow tine was 39.1 (12-80), 48.2 (16-79), and
36.8 (12-80) months after RARP; mean pre-RARP PSA was 13.1, 19.2, and
12.4 ng/mL. In the BCR+ group, 15.0% cases with PSM+. In the BCR- group,
the PSM+ cases were 19.1%. In the 41 patients with PSM+, there were 3
(9.1%) with BCR+ during the follow-up. In the 178 patients whowere PSM-,
17 (9.5%) cases developed BCR+. The mean BCR time after RARP was 9.4 (4-
28) months.
Conclusion: Our limited data indicate that surgical margin status is not an
independent predictor of PSA recurrence in patients who underwent RARP
as deﬁnitive local therapy for prostate cancer.
NDP101:
COMPARE BALLOON DILATATION WITH DIRECT ZERO DEGREE
TELESCOPE DISSECTION OF RETROPERITONEAL SPACE FOR
UNROOFING OF RENAL CYST IN TAIPEI CITY HOSPITAL EXPERIENCE
Jehow cheng 1,2, Yu-Wei Lai 1,2, Thomas Y. Hsueh 1,2, Andy C. Huang 1,2, Yi-
Chun Chiu 1,2, Shiou-Sheng Chen 1,2, Allen W. Chiu 1,2. 1Divisions of Urology,
Department of Surgery, Taipei City Hospital, Taiwan; 2National Yang-Ming
University, School of Medicine, TaiwanPurpose: To Compare the results of balloon dilatation with direct zero
degree telescope dissection of retroperitoneal space for unrooﬁng of renal
cyst
Materials and methods: Total sixteen patient had undergone retro-
peritoneoscopic cyst unrooﬁng at our hospital during January 2010 to
December 2014 were collected and analyzed. Sixteen patients
with symptomatic simple renal cysts had undergone unrooﬁng of the
cyst with balloon dilatation (BD) in nine cases and direct zero degree
telescope dissection (DZDTD) in eight others. Three trocars (10 mm,
10 mm and 5 mm) were inserted in all the procedure. A 2 cm ﬂank
muscle-split incision was made and retroperitoneoscopy was per-
formed through the same incision in all the procedure. Then, the cyst
was unroofed
Results: The mean operative time was 64.4 minutes in the DZDTD group
and 85.6 minutes in the BA group. The In the DZDTD group, the mean
postoperative staywas 4 days, and the time to feedingwas 9.4 hours. In the
BD group, the mean postoperative stay was 4.6 days, and the time to
feeding was 37.4 hours.
Estimated blood loss in the DZDTD group was 56mL. Estimated blood
loss in the BD group was 46mL. No case required conversion to open
surgery. No signiﬁcant intraoperative complication was noted. Only
No patient need blood transfusion. The postoperative complication rate
was 0%. Most complications were minor and did not need speciﬁc
treatment.
Conclusion: DZDTD and BD techniques for unrooﬁng of renal cysts
are safe, effective and minimally invasive. DZDTD is easy to perform
and seem to be a more time-saving procedure when compared to BD.
DZDTD seem be feasible and effective to treat symptomatic simple renal
cysts.Andrology
NDP102:
THE EXPERIENCE OF IMPLEMENTING SMOKING CESSATION TO
IMPROVE SEXUAL HEALTH IN MEN
Wei-Che Weng 1, Hui-Cheng Tseng 2. 1Department of Urology, Kaohsiung
Municipal United Hospital, Taiwan; 2College of Nursing, Kaohsiung Medical
University, Taiwan
Purpose: Erectile dysfunction is considered a signiﬁcant public health
problem and is estimated to affect over 180million men in theworld. Large
cross-sectional and longitudinal epidemiological studies indicated that
chronic smokers are about 1.5 t 2-times as likely as nonsmokers to report
erectile dysfunction after controlling for age and confounding cardiovas-
cular risk factors. Although stopping smoking enhances many aspects of
health, the positive health beneﬁts of smoking cessation are not sufﬁcient
enough for many smokers to considered quitting. The aim of this studywas
to examine whether smoking cessation was associated with sexual health
improvements, with the hope that the results could inﬂuence men to stop
smoking.
Materials and Methods: The male smokers, irrespective of erectile
dysfunction status, who were motivated to stop smoking, were enrolled
in a 12-week smoking cessation program using a nicotine transdermal
patch treatment and adjunctive counseling. The participants were
accessed at smoking regularly, at mid-treatment and at a 4-week post
cessation follow-up. Circumferential change and subjective sexual arousal
indices, as well as self-report sexual functioning were assessed at each
visit.
Results: There were total 65 smoking men involved in our study and
completed the follow-up. There were 20 successful quitters and 45
relapsed men. The quitted showed enhanced erectile tumescence re-
sponses, and faster onset to reach maximum subjective sexual arousal
compared with the relapse men.
Conclusion: Smoking cessation signiﬁcantly enhances both physiological
and self-reported indices on sexual health in long term male smoker,
irrespective of baseline erectile impairment. We hoped that this result may
serve as a novel means to motivate men to stop smoking. The cigarette
smoking brings about the cardiovascular ﬂow change and it is the main
cause of erectile dysfunction. Smoking cessation was found to improve
both physiological and self-reported indices on sexual health in long term
Abstracts / Urological Science 26 (2015) S50eS81 S77male smoker in our study. This result may encourage the smoking men to
stop smoking to enhance their erectile function.
NDP103:
MANAGEMENT OF ERECTILE DYSFUNCTION IN PATIENTS WHO FAILED
PRIOR VASCULAR INTERVENTION
Cheng-Hsing Hsieh 1, Geng-Long Hsu 2,3, Shyh-Chyan Chen 3, Chih-Yuan
Hsu 2. 1Division of Urology, Taipei Tzu Chi Hospital, The Buddhist Tzuchi
Medical Foundation; School of Medicine, Buddhist Tzu-Chi University,
Hualien, Taiwan; 2Microsurgical Potency Reconstruction and Research
Center, Hsu's Andrology, Taipei, Taiwan; 3Department of Urology, National
Taiwan University Hospital, College of Medicine, Taipei, Taiwan
Purpose: Varied penile vascular interventions are still controversial and
commonly regarded as experimental settings. Disappointing outcome and
penile dysmorphology are major concerns along with other complications.
To explode whether our penile venous stripping can salvage other
methods of vascular treatment, we report our experience.
Materials and Methods: From 2010 to 2014, 11consecutive patients
sought our assistance owing to disappointing prior vascular in-
terventions elsewhere. The abridged ﬁve-item version of the Interna-
tional Index of Erectile Function (IIEF-5) was used to score the patients. A
circumferential incision was ﬁrst made to access the deep dorsal veins
and cavernosal veins which were stripped thoroughly and ligated with 6-
0 nylon sutures. A median longitudinal pubic incision was used to com-
plete the stripping proximally and the para-arterial veins were just
ligated segmentally. Finally the wound was fashioned layer by layer with
5-0 chromic suture.
Results: The operation time was from 4.0 to 8.5 hours. The follow-up
period ranged from 0.6-4.0 years. Overall all patients reported satisfactory
penile morphology postoperatively while the preoperative and post-
operative IIEF-5 scores was signiﬁcant difference (8.8± 2.6 vs.16.6± 2.8,
P < 0.001).
Conclusion: This series of salvaging venous surgeries, though technically
challenging, was exclusively beneﬁcial and appeared a viable option to
patients who had undergone prior vascular interventions.
NDP104:
EVALUATION OF PENILE BLOOD FLOW INCLUDING PEAK SYSTOLIC
VELOCITY, END DIASTOLIC VELOCITY AND RIGIDITY INDEX: FIVE
PATIENTS OF ERECTILE DYSFUNCTION EXPERIENCE IN SHIN KONG
MEMORIAL HOSPITAL IN ONE YEAR
Chao Wei Tseng, Thomas I.S. Hwang. Division of Urology, Department of
Surgery, Shin Kong WHS Memorial Hospital, Taipei, Taiwan
Purpose: Erectile dysfunction is very common at the age of above 40s. The
previous studies from Taiwan revealed around 50% male had ED problem
once before. The psychological or physiological aspects both inﬂuence
pathway of tumecence and rigidity. Most of the patients had a lot of
improvement from PDE5 inhibitors, such as Viagra, Cialis, Levitra. It seems
that carvernosal artery plays a key role of tumecence. We evaluate the
patients with ED who had examined peak systolic velocity (PSV) and end
diastolic velocity (EDV).
Materials and Methods: We review charts from patients of erectile
dysfunctionwho had examined his penile blood ﬂow status including PSV/
EDV/RI. We also record his testosterone level, triglyceride and total
cholesterol.
Results: We had investigated ﬁve patients. The age ranges from 24 to 70
years old. The testosterone level ranges from 3.4ng/ml to 6.6ng/ml (1.75ng/
ml~7.81ng/ml).
Peak systolic velocity after alprostadilintracoporeal injection range from
11.39ml/sec to 21.82ml/sec.
Conclusion: The penile blood ﬂow from Doppler ultrasound is a very
useful tool for evaluating erectile dysfunction.We think that penile blood
ﬂow evaluation as a routine examination for patient of erectile dysfunc-
tion.Female Urology & Urodynamics
NDP105:
RISK OF ENDOMETRIAL CANCER IN WOMEN WITH PELVIC
INFLAMMATORY DISEASE: A NATIONWIDE POPULATION-BASED
RETROSPECTIVE COHORT STUDY
Teng-Kai Yang 1, Shiu-Dong Chung 2, Chih-Hsin Muo 3, Chao-Hsiang
Chang 4, Chao-Yuan Huang 5, Chi-Jung Chung 6. 1 Surgery department,
Yonghe Cardinal Hospital, New Taipei city, Taiwan; 2Division of Urology
Department of Surgery, Far Eastern Memorial Hospital, New Taipei, Taiwan;
3Department of Public Health, China Medical University, Taichung, Taiwan;
4Department of Urology, China Medical University and Hospital, Taichung,
Taiwan; 5Department of Urology, National Taiwan University Hospital,
Taipei, Taiwan; 6Department of Health Risk Management, College of Public
Health, China Medical University, Taichung, Taiwan
Purpose: Endometrial cancer (EC) is fatal with rising incidence and mor-
tality. Pelvic inﬂammatory disease (PID), a common gynecologic disease,
had been connected to EC, but the evidence was scarce. We aimed to
investigate the association between PID and EC.
Materials and Methods: We constituted a nationwide population-based
cohort study and data were obtained from the National Health Insurance
Research Database (NHIRD).We deﬁned 41065 patients with PID as the PID
group, and 82130 randomly selected patients as the comparison group
through frequency matching by age and index year. Diagnosis of related
diseases was conducted according to the International Classiﬁcation of
Diseases, Ninth Revision, Clinical Modiﬁcation (ICD-9-CM). Each patient
was individually tracked to identify those who developed EC. Cox pro-
portional hazards regression and the Kaplan-Meier method were used in
the analysis.
Results: Overall, the incidence rate of 9.6 and 16.1 per 100000 person-
year and mean follow-up duration of 4.84 and 6.63 years were observed
among patients in the PID and non-PID cohorts, respectively. After
adjusting for potential risk factors, PID women were observed to have a
1.78-fold higher risk of developing endometrial cancer compared with the
non-PID cohort. Consideration for other potential risk factors, the inci-
dence of EC increased with ageing, particular for those aged over 50 years
(HR ¼ 2.44, 95% CI ¼ 1.28-4.63). In addition, for women with hyperten-
sion, the increased EC risk was also shown in PID patients compared to
non-PID cohort.
Conclusion: In the large-scale population-based study, we indicated
the increased EC risk in PID patients, particular for patients with older
age or those with hypertension. Future, large-scale clinical trial would be
required to clarify the role of medication played in PID-related EC progress.
NDP106:
INTRAVESICAL HYALURONIC ACID TREATMENT MAY IMPROVE LOWER
URINARY TRACT SYMPTOMS CAUSED BY KETAMINE-ASSOCIATED
CYSTITIS: PRELIMINARY RESULT
En Meng 1,2, Sheng-Tang Wu 1,2, Chih-Wei Tsao 1,2, Shou-Hung Tang 1,2, Tai-
Lung Cha 1,2, Guang-Huan Sun 1,2, Dah-Shyong Yu 1,2, Sun-Yran
Chang 1,2. 1Division of Urology, Department of Surgery, Tri-Service General
Hospital, National Defense Medical Center, Taipei, Taiwan, ROC;
2Department of Pathology, Tri-Service General Hospital, National Defense
Medical Center, Taipei, Taiwan, ROC
Purpose: Long term ketamine abuse may cause variable lower urinary
tract symptoms (LUTS) and severe cystitis. The clinical features of keta-
mine associated cystitis (KC) are very similar to bladder pain syndrome/
interstitial cystitis (BPS/IC). Intravesical administration of hyaluronic acid
(HA) is one of the regimens for treating BPS/IC. In this study, we aim to
investigate whet her intravesical HA therapy may improve the LUTS of
patients with KC.
Materials and Methods: 4 female and 1 male patients with KC who failed
oral medications were enrolled in this study. Hyaluronic acid (Cystistat®)
at a dose of 40 mg in a volume of 50 ml of phosphate-buffered saline was
injected into the bladder on a weekly basis for 6 weeks and then monthly
for a further 3 months. Response to therapy was evaluated by Visual
Analogue Scale for pain (VAS), International Prostate Symptom Score
